Peptide Process Development & CMC Summit: Advancing Peptide Therapeutics
In the wake of significant achievements in synthetic peptide therapeutics, such as Novo Nordisk’s $6 billion peptide expansion, Merck’s advancements in macrocyclic peptides, and Genentech’s partnership with Peptidream, peptides are transforming drug development pipelines. Despite these successes, challenges remain in the advanced synthesis of complex peptides and commercial-scale manufacturing for large patient populations.
The Peptide Process Development & CMC Summit is your comprehensive resource to:
- Synthesize Complex Peptides: Develop next-generation cyclic and macrocyclic peptides to widen the therapeutic index of peptide therapeutics.
- Optimize Traditional Synthesis Techniques: Enhance efficiency in peptide synthesis and purification for high-quality production.
- Explore Alternatives to SPPS: Evaluate biological, solid-phase, and liquid-phase synthesis methods to select the most efficient approach to reduce overall production costs.
- Understand Control Strategies and CMC Requirements: Ensure regulation compliance and quality in peptide development for seamless technology transfer.
- Manufacture Peptides at Scale: Produce peptides for clinical development and get drugs to patients faster.
Join us this July, where 50+ experts in Analytical, Process Development, and CMC will converge. This exclusive event focuses on synthetic peptide upstream and downstream process development, covering everything from conjugates to cyclic peptides. Engage with experts from Lilly, Merck, BioNTech, and Pfizer to revolutionize your approach and embrace the future of peptide-driven drug development.
Registration for the conference is now open, with early bird discounts available until Friday, June 7.
Join us at the Peptide Process Development & CMC Summit and be part of the revolution in drug delivery that will shape the future of healthcare.